To be consistent with these findings, overexpression of ERBB2 in gallbladder epithelium leads to the development of adenocarcinoma in 100% of transgenic mice by 3 months of age through activating MAP kinase pathways [29]. This evidence concerns the gene ERBB2 and adenocarcinoma.